Lancement du Centre d’excellence sur la douleur chronique pour les vétérans canadiens
14 mai 2020 14h18 HE
|
Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 14 mai 2020 (GLOBE NEWSWIRE) -- Centre d’excellence sur la douleur chronique pour les vétérans canadiens Le Centre d’excellence sur la douleur chronique pour les vétérans...
Launch of the Chronic Pain Centre of Excellence for Canadian Veterans
14 mai 2020 14h18 HE
|
Chronic Pain Centre of Excellence for Canadian Veterans
HAMILTON, Ontario, May 14, 2020 (GLOBE NEWSWIRE) -- Chronic Pain Centre of Excellence for Canadian Veterans The Chronic Pain Centre of Excellence for Canadian Veterans (Centre of Excellence) is...
Study of Sprint Peripheral Nerve Stimulation System Demonstrates 12 Months of Low Back Pain Relief Following 60-Day Treatment
21 janv. 2020 08h55 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding...
Study Demonstrates 12-Month Relief of Post-Amputation Pain Following Treatment With SPRINT PNS System
10 déc. 2019 08h29 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 10, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of 12-month follow up results of its...
SPR Therapeutics Announces 1000th Sprint PNS Procedure
04 déc. 2019 08h30 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
Montu Group Launches Medical Cannabis Brand Circle Into Australian Market
28 nov. 2019 15h00 HE
|
Montu Group Pty Ltd
MELBOURNE, Australia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Montu Group Pty. Ltd (“Montu Group” or the “Company”), a leading medical cannabis company with presence in Europe and Asia-Pacific, is pleased...
Aptinyx to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
05 nov. 2019 08h07 HE
|
Aptinyx Inc.
EVANSTON, Ill., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic
02 oct. 2019 08h00 HE
|
Adynxx, Inc.
SAN FRANCISCO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Allsup Supports U.S. Pain Foundation in Bringing Attention to Chronic Pain during National Pain Awareness Month
23 sept. 2019 11h57 HE
|
Allsup
Belleville, Illinois, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Allsup, the nation’s premier disability representation company, remains committed to supporting the significant contributions of the U.S....
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28 août 2019 07h45 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...